Skip to main content
JAMA Network logoLink to JAMA Network
. 2025 Apr 16;82(6):627. doi: 10.1001/jamapsychiatry.2025.0781

Error in Figure

PMCID: PMC12004239  PMID: 40238093

In the Special Communication titled “Modifying Informed Consent to Help Address Functional Unmasking in Psychedelic Clinical Trials,”1 published online January 8, 2025, and in the March 1, 2025, issue, there was an error in the Figure. The second question in the decision tree reversed the response boxes in relation to the guidelines. This article was corrected online to make the decision tree accurate and easier to interpret.

Reference

  • 1.Matvey M, Kelley DP, Bradley ER, Chiong W, O’Donovan A, Woolley J. Modifying informed consent to help address functional unmasking in psychedelic clinical trials. JAMA Psychiatry. 2025;82(3):311-318. doi: 10.1001/jamapsychiatry.2024.4312 [DOI] [PubMed] [Google Scholar]

Articles from JAMA Psychiatry are provided here courtesy of American Medical Association

RESOURCES